The latest health news includes Johnson & Johnson halting testing on a depression drug, USDA eliminating food safety advisory ...

Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of stock of BioAge Labs, Inc. pursuant and/or traceable to the registration statement for BioAge's initial public offering ...

Rosen Law Firm achieved the largest ever securities class action settlement against a Chinese ... Defendants also mentioned its collaboration with Eli Lilly and Company's ("Lilly") Chorus clinical ...

restricting copies of Lilly weight-loss drug A U.S. federal judge has refused to allow compounding pharmacies to keep making copies of Eli Lilly's popular weight-loss and diabetes drugs Zepbound ...

Australia's PolyNovo chief steps down after reports of rift with chair Australian biotech company PolyNovo said on Tuesday it has removed its CEO after discussions with the executive last week ...

Compounders had been allowed to produce and sell hundreds of thousands of their own versions of popular anti-obesity drugs, so long as the FDA considered them in shortage.

Eli Lilly Chief Executive David Ricks annual compensation rose to $29.2 million in 2024, a 10% increase from the $26.2 million he received a year earlier. Ricks' payout included $19.7 million in ...

Earlier this week, Eli Lilly partnered up with telehealth providers LifeMD and Teladoc Health to offer its lower cost, single-vial Zepbound (tirzepatide) to patients in the virtual care companies ...

A federal judge has effectively ended the ability of compounding pharmacies to make their own copies of Eli Lilly’s weight ... tirzepatide. The lawsuit against the FDA was brought in October ...

Plenty of health care names are under accumulation right now. But there’s a powerful fundamental story happening with Eli Lilly. Also, EPS is estimated to ramp higher this year by +27.4%.